EUVIMEDEUVIMED entdecken
Crossref

Mechanism of FOXP2 in the Hepatocellular Carcinoma Progression via Ferroptosis Through RBM15B-Mediated m6A Modification

Wenquan Liu, Jiaqi He, Jing Zheng, Qiqi Tang

Applied Biochemistry and Biotechnology · 2026

DOI: 10.1007/s12010-025-05554-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, 2026. Verfasst von Wenquan Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The Second Affiliated Hospital of Jiujiang University, Jiujiang, China. WenquanLiuu@163.com. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms, RNA-Binding Proteins. Die Arbeit nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HCC predominantly develops in individuals with chronic hepatic conditions and liver cirrhosis, which is marked by high mortality. This study investigates the functional roles and molecular mechanisms by which FOXP2 modulates HCC progression through ferroptosis. After HCC and normal cells were cultured, the expression of FOXP2, RBM15B, and KDM4C was analyzed using western blot or RT-qPCR. After FOXP2 intervention, cellular metabolic activity was assessed via CCK-8 assay, while replicative capacity was quantified through EdU staining and colony formation assays; key regulators of ferroptosis were analyzed by western blot; iron content and oxidative stress levels were measured. The binding between FOXP2 and RBM15B was investigated through ChIP and dual-luciferase assays. Dual-luciferase reporter assay was used to verify the regulation of RBM15B on KDM4C via m6A modification. MeRIP was utilized to examine m6A enrichment on KDM4C mRNA. ChIP was employed to examine the enrichment of KDM4C and H3K9me3 on SLC7A11 promoters. Combined experiments investigated the role of the RBM15B/KDM4C axis in FOXP2-mediated ferroptosis and HCC cell proliferation. Xenograft models were developed in nude mice to validate the mechanism. FOXP2 expression was downregulated in HCC. FOXP2 overexpression significantly inhibited HCC cell proliferation and promoted ferroptosis. FOXP2 repressed RBM15B expression, suppressed the RBM15B-mediated m6A modification, inhibited KDM4C expression, upregulated H3K9me3 levels, and suppressed SLC7A11 expression, ultimately enhancing ferroptosis. Overexpression of RBM15B or KDM4C attenuated ferroptosis and reversed the suppression of HCC cell growth induced by FOXP2 overexpression. In conclusion, FOXP2 may promote ferroptosis and inhibit cell proliferation in HCC by decreasing SLC7A11 expression via the RBM15B/KDM4C axis in an m6A-dependent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCarcinoma, HepatocellularLiver NeoplasmsRNA-Binding ProteinsForkhead Transcription FactorsDisease ProgressionHumansAnimalsMiceMice, NudeAmino Acid Transport System y+RNA MethylationCell ProliferationCell Line, TumorAdenosine

Stichwörter der Autor:innen

FOXP2FerroptosisHepatocellular carcinomaKDM4CRBM15Bm6A

Substanzen

RNA-Binding ProteinsForkhead Transcription FactorsSLC7A11 protein, humanN-methyladenosineAmino Acid Transport System y+Adenosine

Autor:innen und Institutionen

  • Department of Medical Oncology, The Second Affiliated Hospital of Jiujiang University, Jiujiang, China. WenquanLiuu@163.com.
  • Department of Medical Oncology, The Second Affiliated Hospital of Jiujiang University, Jiujiang, China.

Zitieren

APA

Liu, W., He, J., Zheng, J., & Tang, Q. (2026). Mechanism of FOXP2 in the Hepatocellular Carcinoma Progression via Ferroptosis Through RBM15B-Mediated m6A Modification. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-025-05554-0

Vancouver

Liu W, He J, Zheng J, Tang Q. Mechanism of FOXP2 in the Hepatocellular Carcinoma Progression via Ferroptosis Through RBM15B-Mediated m6A Modification. Applied Biochemistry and Biotechnology. 2026. doi:10.1007/s12010-025-05554-0

BibTeX
@article{Liu2026,
  author = {Liu, Wenquan and He, Jiaqi and Zheng, Jing and Tang, Qiqi},
  title = {Mechanism of FOXP2 in the Hepatocellular Carcinoma Progression via Ferroptosis Through RBM15B-Mediated m6A Modification},
  journal = {Applied Biochemistry and Biotechnology},
  year = {2026},
  doi = {10.1007/s12010-025-05554-0}
}
Kostenlos starten →